SCHEMBL16626406

SCHEMBL16626406

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3ccc(C#N)cc3C)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 5/20 0.39
IDE P14735 1/20 0.36
NAMPT P43490 2/20 0.35
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
ALPL P05186 1/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
CYP19A1 P11511 1/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
GFER P55789 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PIK3CA P42336 1/20 0.31
MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16619163 0.99 HTR6 (0.39) HTR6IDENAMPTPTGS1PTGS2
SCHEMBL16626407 0.92 HTR6 (0.39) HTR6IDENAMPTPTGS1PTGS2
SCHEMBL16626435 0.91 LRRK2 (0.39) HTR6IDENAMPTPTGS1PTGS2
SCHEMBL16626684 0.91 HTR6 (0.39) HTR6IDENAMPTPTGS1PTGS2
Hydrochloric Acid SCHEMBL16618890 0.91 HTR6 (0.39) HTR6IDENAMPTPTGS1PTGS2
Hydrochloric Acid SCHEMBL16619391 0.90 HTR6 (0.38) HTR6IDENAMPTPTGS1PTGS2
Hydrochloric Acid SCHEMBL16619036 0.90 LRRK2 (0.39) HTR6IDENAMPTPTGS1PTGS2
SCHEMBL16626423 0.90 CYP19A1 (0.38) HTR6IDENAMPTCYP19A1PDE4A
Hydrochloric Acid SCHEMBL16619228 0.89 CYP19A1 (0.37) HTR6IDENAMPTCYP19A1PDE4A
SCHEMBL16626426 0.89 BACE2 (0.41) HTR6IDENAMPTPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885IDE 2586/4885NAMPT 1610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.